CareDx (CDNA) EBITDA Margin: 2013-2025
Historic EBITDA Margin for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to -0.25%.
- CareDx's EBITDA Margin rose 1631.00% to -0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.66%, marking a year-over-year increase of 6981.00%. This contributed to the annual value of 12.21% for FY2024, which is 8476.00% up from last year.
- According to the latest figures from Q3 2025, CareDx's EBITDA Margin is -0.25%, which was up 98.08% from -12.83% recorded in Q2 2025.
- CareDx's EBITDA Margin's 5-year high stood at 97.46% during Q4 2024, with a 5-year trough of -187.03% in Q4 2023.
- In the last 3 years, CareDx's EBITDA Margin had a median value of -16.55% in 2024 and averaged -26.17%.
- In the last 5 years, CareDx's EBITDA Margin crashed by 16,382bps in 2023 and then soared by 28,449bps in 2024.
- CareDx's EBITDA Margin (Quarterly) stood at -19.44% in 2021, then slumped by 377bps to -23.21% in 2022, then crashed by 16,382bps to -187.03% in 2023, then skyrocketed by 28,449bps to 97.46% in 2024, then spiked by 1,631bps to -0.25% in 2025.
- Its EBITDA Margin was -0.25% in Q3 2025, compared to -12.83% in Q2 2025 and -15.79% in Q1 2025.